Lysyl oxidase-like 2 (LOXL-2), a collagen-modifying enzyme, has been found to increase the stiffness of tumor tissue by modifying the ECM components in the TME in HCC, thereby promoting intrahepatic metastasis (Wong et al., 2014). Here, LOXL2 is linked to hepatocellular carcinoma.